Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
RNA
#1652
Avidity Biosciences, Inc. Common Stock
14.750
0
-79.74%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-79.74%
Changement Mensuel
-79.67%
Evolution sur 6 mois
-79.03%
Changement Annuel
-79.03%
Clôture Précédente
72.800
0
Open
14.750
0
Bid
Ask
Low
14.750
0
High
14.750
0
Volume
25
Marchés
Actions des Marchés US
Soins de Santé
RNA
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
119.31 M
120.21 M
120.54 M
128.65 M
150.68 M
155.15 M
—
Valuation ratios
Enterprise value
5.11 B
3.28 B
3.3 B
3.41 B
6.21 B
10.81 B
23.74 B
Price to earnings ratio
-15.95
-10.06
-9.87
-8
-10.42
-14.51
-42.81
Price to sales ratio
422.46
297.77
384
324.84
274.09
529.62
1 512.55
Price to cash flow ratio
26.69
10.78
9.84
7.22
9.61
15.27
41.94
Price to book ratio
1.15
2.28
0.63
0.64
0.95
5.88
8.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
-0.07
-0.08
-0.11
-0.08
-0.12
-0.4
Return on equity %
0.05
-0.07
-0.09
-0.13
-0.09
-0.14
-0.45
Return on invested capital %
—
136.67
—
—
—
-34.91
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
4 200.9
-4 069.59
-8 360.9
-4 448.71
-1 513.47
-29.59 K
-43.91 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
3 441.7
-3 439.49
-7 360.01
-4 089.29
-1 398.33
-27.57 K
-40.42 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
17.76
15.73
16.91
9.26
11.57
9.2
46.94
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0.01
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.62
-0.9
-0.97
-1.54
-1.18
-1.23
-4.92
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
15.11
13.44
10.83
9.27
2.65
2.78
25.53
Net current asset value per share
15.31
13.82
11.1
9.66
14.86
13.06
48.69
Tangible book value per share
14.2
12.77
10.28
9.21
14.26
12.26
46.02
Working capital per share
14.45
12.94
10.45
8.62
13.58
11.64
44.28
Book value per share
14.2
12.77
10.28
9.21
14.26
12.26
46.02
Nouvelles
Morning News Wrap-Up 2/27/26: Today’s Biggest Stock Market Stories! - TipRanks.com
Le BPA de Avidity Bio a manqué les attentes de 0,30$, le CA en dessous des prévisions
Avidity Bio earnings missed by $0.30, revenue fell short of estimates
Avidity reporte l’assemblée des actionnaires, fixe les dates de fusion
Avidity postpones stockholder meeting, sets merger dates
BB Biotech 2025 : bénéfice en hausse de 660%, prudence pour 2026
Le médicament d’Avidity contre la dystrophie myotonique montre des résultats prometteurs
Avidity’s myotonic dystrophy drug shows promising results in trial
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Vaccine Makers Curtail Research and Cut Jobs
U.S. Health Officials Defend Rejection of Moderna’s Flu Vaccine
F.D.A. Refuses to Review Moderna Flu Vaccine